RESULTS: There were no significant differences in micturition pressure, threshold pressure, voided volume, post-void residual, bladder capacity or voiding efficiency among 3 groups. The number of non-voiding contractions (NVCs) per a voiding cycle in groups B and C were significantly lower than that of group A. NGF levels of the bladder mucosa and spinal cord of SCI mice (group A) were significantly increased compared with spinal intact mice. Two-weeks (group C), but not one-week (group B), anti-NGF treatment significantly decreased bladder mucosal and spinal NGF expression. The mRNA levels of TRPA1 and TRPV1 were increased in SCI mice compared to spinal intact mice, and significantly decreased after both 1 week and 2 weeks of anti-NGF treatment.
INTRODUCTION AND OBJECTIVES: Many rats with chronic suprasacral spinal cord injury (SCI) demonstrate hind limb locomotor activity (HLLA) in response to external crede or high pressure contractions during cystometry. We propose that this aberrant, pressuredriven bladder reflex pathway may be harnessed to facilitate walking in SCI patients. As a first step in exploring this possibility, we examined the relationship between intravesical pressure (IVP) and HLLA in chronic suprasacral SCI rats.
METHODS: Female rats (4 weeks post-SCI at T9-10, n¼16) were anesthetized with isoflurane and fitted with transvesical catheters and right quadriceps EMG electrodes to monitor bladder and hind limb locomotor activities, respectively. The animals were mounted in Ballman restraint cages to which they had been previously acclimated. The catheter was connected to a pressure transducer, an infusion pump, and a saline-filled reservoir mounted on a metered vertical pole (pressure clamp). After 30 min of recovery from anesthesia, the bladder was filled at 0.1 ml/min with saline to verify bladder-to-bladder reflex activity for 30 min. IVP was then increased in an interrupted stepwise fashion from 0-120 cmH2O at 10 cmH2O increments. Each step consisted of five minutes: 3 minutes at the new pressure followed by 2 minutes at 0 cmH2O. IVP and the number of HLLA events (as defined by rhythmic EMG discharges of 3-10 cycles/event) were recorded for each pressure step. This process was repeated for two more trials for each rat to assess the durability of the reflex. Data were analyzed using ANOVA with repeated measures both within and across pressure escalation trials. P<0.05 was considered significant.
RESULTS: ANOVA revealed that locomotor events increased with increasing intravesical pressure and decreased with the number of escalation trials (P<0.0001 for both effects). The increase in the number of locomotor events with increasing intravesical pressure appeared to plateau at~50-60 cmH2O (P<0.05 for all). The average of the maximal number of locomotor events for each animal decreased steadily from~3.0, 2.5 and 1.75 over the three trials.
CONCLUSIONS: There is a positive relationship between IVP and HLLA that suggests the emergence of an aberrant bladder-to-hind limb locomotor reflex pathway following SCI. It may be possible to harness this reflex pathway independently of the state of the bladder to facilitate walking in SCI patients.
Source of Funding: This work was funded by a grant from the VA RRD SPiRE RX-001749-01
MP85-03 THE THERAPEUTIC EFFECT OF TRPV4 ACTIVATION IN THE BLADDER ON UNDERACTIVE BLADDER IN RATS WITH PELVIC NERVE CRUSH
Ei-ichiro Takaoka*, Shun Takai, Takahisa Suzuki, Nobutaka Shimizu, Joonbeom Kwon, Hiroki Okada, Pittsburgh, PA; Hiroyuki Nishiyama, Tsukuba, Japan; Naoki Yoshimura, Christopher J. Chermansky, Pittsburgh, PA INTRODUCTION AND OBJECTIVES: Incomplete bladder emptying due to detrusor underactivity (DU) is a significant urological problem underlying underactive bladder (UAB). Also, TRPV4 has been reported to be one of the mechanosensitive channels expressed in the bladder. In this study, we sought to produce a consistent rat model of UAB with the modification of our previous model of pelvic nerve crush (PNC) (2016 AUA) and evaluated the therapeutic effect of intravesical application of a TRPV4 agonist on the UAB condition.
METHODS: In female Sprague-Dawley rats, the visceral branches of bilateral pelvic nerves were identified near the internal iliac vessels and bilateral PNC was made by two times of nerve compression of either side with each 20-seconds duration using sharp forceps. After 10 days, awake cystometrograms (CMG) were recorded in sham control and PNC rats. Then, in both groups, a TRPV4 agonist (GSK1016790A) was continuously administered into the bladder and the CMG parameters were compared before and after intravesical drug administration.
RESULTS: The bladder weight was significantly increased in PNC rats vs. control rats. In CMG, PNC rats showed significant increases in voided volume, post-void residual urine volume, and residual urine rate compared to control rats. PNC rats also revealed the significant increases in intercontraction intervals (ICI), a number of nonvoiding contractions, and threshold pressure while the amplitude during voiding was significantly decreased (table). In the TRPV4 administration study, intravesical application of 1.5mM of GSK 1016790A significantly decreased ICI, voided volume, and post-void residual urine volume in PNC rats while it did not significantly affect any CMG parameters in control rats.
CONCLUSIONS: Rats with pelvic nerve injury induced by the modified PNC method, which showed the characteristics of DU, seem to be an appropriate model for evaluation of peripheral neurogenic mechanisms of UAB. Also TRPV4 that reduced the bladder capacity and residual urine volume could be a potential target for the treatment of UAB.
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